nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Ototoxicity—Cisplatin—bone cancer	0.116	0.116	CcSEcCtD
Capreomycin—Nephrotoxicity—Cisplatin—bone cancer	0.0731	0.0731	CcSEcCtD
Capreomycin—Injection site haemorrhage—Epirubicin—bone cancer	0.0443	0.0443	CcSEcCtD
Capreomycin—Injection site haemorrhage—Doxorubicin—bone cancer	0.041	0.041	CcSEcCtD
Capreomycin—Nephropathy toxic—Cisplatin—bone cancer	0.0405	0.0405	CcSEcCtD
Capreomycin—Abscess—Cisplatin—bone cancer	0.0294	0.0294	CcSEcCtD
Capreomycin—Hearing impaired—Cisplatin—bone cancer	0.0244	0.0244	CcSEcCtD
Capreomycin—Pain—Carboplatin—bone cancer	0.0242	0.0242	CcSEcCtD
Capreomycin—Hepatocellular injury—Cisplatin—bone cancer	0.0233	0.0233	CcSEcCtD
Capreomycin—Body temperature increased—Carboplatin—bone cancer	0.0224	0.0224	CcSEcCtD
Capreomycin—Urine abnormality—Epirubicin—bone cancer	0.0216	0.0216	CcSEcCtD
Capreomycin—Urine analysis abnormal—Epirubicin—bone cancer	0.0203	0.0203	CcSEcCtD
Capreomycin—Urine abnormality—Doxorubicin—bone cancer	0.02	0.02	CcSEcCtD
Capreomycin—Deafness—Cisplatin—bone cancer	0.0189	0.0189	CcSEcCtD
Capreomycin—Hypomagnesaemia—Epirubicin—bone cancer	0.0188	0.0188	CcSEcCtD
Capreomycin—Urine analysis abnormal—Doxorubicin—bone cancer	0.0188	0.0188	CcSEcCtD
Capreomycin—Liver disorder—Methotrexate—bone cancer	0.0187	0.0187	CcSEcCtD
Capreomycin—Hypomagnesaemia—Doxorubicin—bone cancer	0.0174	0.0174	CcSEcCtD
Capreomycin—Abscess—Methotrexate—bone cancer	0.0161	0.0161	CcSEcCtD
Capreomycin—Hypokalaemia—Cisplatin—bone cancer	0.0154	0.0154	CcSEcCtD
Capreomycin—Abscess—Epirubicin—bone cancer	0.0151	0.0151	CcSEcCtD
Capreomycin—Abscess—Doxorubicin—bone cancer	0.014	0.014	CcSEcCtD
Capreomycin—Oliguria—Methotrexate—bone cancer	0.0138	0.0138	CcSEcCtD
Capreomycin—Hypocalcaemia—Epirubicin—bone cancer	0.013	0.013	CcSEcCtD
Capreomycin—Oliguria—Epirubicin—bone cancer	0.013	0.013	CcSEcCtD
Capreomycin—Renal failure—Cisplatin—bone cancer	0.0128	0.0128	CcSEcCtD
Capreomycin—Hypocalcaemia—Doxorubicin—bone cancer	0.0121	0.0121	CcSEcCtD
Capreomycin—Oliguria—Doxorubicin—bone cancer	0.012	0.012	CcSEcCtD
Capreomycin—Hepatocellular injury—Epirubicin—bone cancer	0.0119	0.0119	CcSEcCtD
Capreomycin—Hepatocellular injury—Doxorubicin—bone cancer	0.0111	0.0111	CcSEcCtD
Capreomycin—Tinnitus—Cisplatin—bone cancer	0.0109	0.0109	CcSEcCtD
Capreomycin—Renal impairment—Epirubicin—bone cancer	0.00911	0.00911	CcSEcCtD
Capreomycin—Leukopenia—Cisplatin—bone cancer	0.0091	0.0091	CcSEcCtD
Capreomycin—Renal impairment—Doxorubicin—bone cancer	0.00843	0.00843	CcSEcCtD
Capreomycin—Thrombocytopenia—Cisplatin—bone cancer	0.00812	0.00812	CcSEcCtD
Capreomycin—Eosinophilia—Methotrexate—bone cancer	0.00793	0.00793	CcSEcCtD
Capreomycin—Hypokalaemia—Epirubicin—bone cancer	0.00789	0.00789	CcSEcCtD
Capreomycin—Eosinophilia—Epirubicin—bone cancer	0.00742	0.00742	CcSEcCtD
Capreomycin—Hypokalaemia—Doxorubicin—bone cancer	0.0073	0.0073	CcSEcCtD
Capreomycin—Pain—Cisplatin—bone cancer	0.00709	0.00709	CcSEcCtD
Capreomycin—Renal failure—Methotrexate—bone cancer	0.00702	0.00702	CcSEcCtD
Capreomycin—Eosinophilia—Doxorubicin—bone cancer	0.00686	0.00686	CcSEcCtD
Capreomycin—Renal failure—Epirubicin—bone cancer	0.00657	0.00657	CcSEcCtD
Capreomycin—Body temperature increased—Cisplatin—bone cancer	0.00656	0.00656	CcSEcCtD
Capreomycin—Hypersensitivity—Cisplatin—bone cancer	0.00611	0.00611	CcSEcCtD
Capreomycin—Renal failure—Doxorubicin—bone cancer	0.00608	0.00608	CcSEcCtD
Capreomycin—Tinnitus—Methotrexate—bone cancer	0.00597	0.00597	CcSEcCtD
Capreomycin—Tinnitus—Epirubicin—bone cancer	0.00559	0.00559	CcSEcCtD
Capreomycin—Rash—Cisplatin—bone cancer	0.00523	0.00523	CcSEcCtD
Capreomycin—Dermatitis—Cisplatin—bone cancer	0.00523	0.00523	CcSEcCtD
Capreomycin—Tinnitus—Doxorubicin—bone cancer	0.00517	0.00517	CcSEcCtD
Capreomycin—Vertigo—Methotrexate—bone cancer	0.00501	0.00501	CcSEcCtD
Capreomycin—Leukopenia—Methotrexate—bone cancer	0.00499	0.00499	CcSEcCtD
Capreomycin—Vertigo—Epirubicin—bone cancer	0.00469	0.00469	CcSEcCtD
Capreomycin—Leukopenia—Epirubicin—bone cancer	0.00467	0.00467	CcSEcCtD
Capreomycin—Thrombocytopenia—Methotrexate—bone cancer	0.00446	0.00446	CcSEcCtD
Capreomycin—Vertigo—Doxorubicin—bone cancer	0.00434	0.00434	CcSEcCtD
Capreomycin—Leukopenia—Doxorubicin—bone cancer	0.00432	0.00432	CcSEcCtD
Capreomycin—Thrombocytopenia—Epirubicin—bone cancer	0.00417	0.00417	CcSEcCtD
Capreomycin—Pain—Methotrexate—bone cancer	0.00389	0.00389	CcSEcCtD
Capreomycin—Thrombocytopenia—Doxorubicin—bone cancer	0.00386	0.00386	CcSEcCtD
Capreomycin—Pain—Epirubicin—bone cancer	0.00364	0.00364	CcSEcCtD
Capreomycin—Urticaria—Methotrexate—bone cancer	0.00362	0.00362	CcSEcCtD
Capreomycin—Body temperature increased—Methotrexate—bone cancer	0.0036	0.0036	CcSEcCtD
Capreomycin—Urticaria—Epirubicin—bone cancer	0.00338	0.00338	CcSEcCtD
Capreomycin—Pain—Doxorubicin—bone cancer	0.00337	0.00337	CcSEcCtD
Capreomycin—Body temperature increased—Epirubicin—bone cancer	0.00337	0.00337	CcSEcCtD
Capreomycin—Hypersensitivity—Methotrexate—bone cancer	0.00335	0.00335	CcSEcCtD
Capreomycin—Hypersensitivity—Epirubicin—bone cancer	0.00314	0.00314	CcSEcCtD
Capreomycin—Urticaria—Doxorubicin—bone cancer	0.00313	0.00313	CcSEcCtD
Capreomycin—Body temperature increased—Doxorubicin—bone cancer	0.00312	0.00312	CcSEcCtD
Capreomycin—Hypersensitivity—Doxorubicin—bone cancer	0.0029	0.0029	CcSEcCtD
Capreomycin—Rash—Methotrexate—bone cancer	0.00287	0.00287	CcSEcCtD
Capreomycin—Dermatitis—Methotrexate—bone cancer	0.00287	0.00287	CcSEcCtD
Capreomycin—Rash—Epirubicin—bone cancer	0.00269	0.00269	CcSEcCtD
Capreomycin—Dermatitis—Epirubicin—bone cancer	0.00268	0.00268	CcSEcCtD
Capreomycin—Rash—Doxorubicin—bone cancer	0.00249	0.00249	CcSEcCtD
Capreomycin—Dermatitis—Doxorubicin—bone cancer	0.00248	0.00248	CcSEcCtD
